Simon Baker analyst REDBURN

Currently out of the existing stock ratings of Simon Baker, 4 are a HOLD (26.67%), 5 are a BUY (33.33%), 6 are a SELL (40%).

Simon Baker

Work Performance Price Targets & Ratings Chart

Analyst Simon Baker, currently employed at REDBURN, carries an average stock price target met ratio of 57.5% that have a potential upside of 18.59% achieved within 453 days. Previously, Simon Baker worked at SOCGEN.

Simon Baker’s has documented 29 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on BNTX, BioNTech SE at 17-May-2023.

Wall Street Analyst Simon Baker

Analyst best performing recommendations are on PSO (PEARSON PLC ADR).
The best stock recommendation documented was for PSO (PEARSON PLC ADR) at 3/1/2022. The price target of $9.32 was fulfilled within 10 days with a profit of $0.98 (11.75%) receiving and performance score of 11.75.

Average potential price target upside

BNTX BioNTech SE HOLX Hologic META Meta Platforms . PSO Pearson PLC ADR WPP WPP PLC ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$122

23 days ago
(02-Dec-2024)

1/2 (50%)

$31.12 (34.24%)

129

Hold

$122

$8.92 (7.89%)

$124

29 days ago
(26-Nov-2024)

5/8 (62.5%)

$3.25 (2.74%)

33

$125

$11.92 (10.54%)

$100

1 months 6 days ago
(19-Nov-2024)

3/5 (60%)

$17.45 (16.23%)

14

Buy

$150

$36.92 (32.65%)

$150

1 months 7 days ago
(18-Nov-2024)

14/31 (45.16%)

$48.99 (48.50%)

69

Hold

$137

$23.92 (21.15%)

$100

1 months 17 days ago
(08-Nov-2024)

4/8 (50%)

$22.54 (19.69%)

95

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Simon Baker?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?